Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 395 participants.

Also called NCT07439133

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 395 participants (planned count) (from the registry)
Sponsor
Sinotau Pharmaceutical Group (from the registry)
Registry
  • NCT NCT07439133
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07439133. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-11-14 (actual); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
Intervention (Drug)
XTR004
Lead sponsor
Sinotau Pharmaceutical Group (class: industry)

Record details

Record id
cardio:ct-nct07439133
Content hash
6e6ece3fc6f3893774acd84d3e82dff4696b437cd0dd8a40af309aa7c58eb03e